Document:

Alkaline Water Company Inc.: Exhibit 10.47 - Filed by newsfilecorp.com

	THE ALKALINE WATER COMPANY INC. 
	 
	SUBSCRIPTION AGREEMENT 
	(UNITS –US$♦ PER UNIT) 
	 
	INSTRUCTIONS TO PURCHASER 

	1. 	
      All purchasers must complete all of the information in
      the boxes on page 2 and sign where indicated with an “X”.

	 	 
	2. 	
      If you are a “U.S. Purchaser”, as defined in the
      “Accredited Investor Questionnaire”, you must complete and sign the
      “Accredited Investor Questionnaire” that starts on page 9.

	 	 
	3. 	
      Certified check or bank draft should be made payable to
      The Alkaline Water Company Inc. For wire instructions, contact Richard A.
      Wright at ricky@wtfcpa.com.

- 2 - 

THE ALKALINE WATER COMPANY INC. 

SUBSCRIPTION AGREEMENT 

The undersigned (the “Subscriber”) hereby irrevocably
subscribes for and agrees to purchase from The Alkaline Water Company Inc. (the
“Company”) that number of units of the Company (each, a “Unit”) as
is set out below at a price of US$♦ per Unit. Each Unit is comprised of one
share of common stock of the Company (each, a “Share”) and one-third of
one share purchase warrant (each whole warrant, a “Warrant”). Each
Warrant will entitle the holder thereof to acquire one Share (each, a
“Warrant Share”) at a price of US$♦ per Warrant Share until 5:00 p.m.
(Mountain time) on the date of expiration of the Warrant, which is 24 months
following the Closing Date (as defined herein). The Subscriber agrees to be
bound by the terms and conditions set forth in the attached “Terms and
Conditions of Subscription for Units”. 

	Subscriber Information 	 
	 	Units to be Purchased 	  
	  	  	 	Number of
      Units:                                                                                                                                       
      
	  	 
    	 	x US$♦ 	 
    
	(Name of Subscriber)
    	  	 	  	=

	  	  	 	  	  
	  	  	 	Aggregate Subscription Price:
      US$                                                                                                        
      
	X 	 
    	 	                 
                         
                   (the “Subscription
      Amount”) 
	(Signature
      of Subscriber – if the Subscriber is an Individual) 	 	 
    	  
	  	  	 	  	  
	X 	 
    	 	 
    	  
	(Signature
      of Authorized Signatory – if the Subscriber is not an Individual) 	 	Please complete if purchasing as agent or trustee for a
      principal (beneficial 
	  	  	 	purchaser) (a “Disclosed Principal”) and not purchasing as
      trustee or agent 
	  	  	 	for accounts fully managed by it. 	 
    
	(Name and
      Title of Authorized Signatory – if the Subscriber is not an 	 	  	 
    
	Individual) 	  	 	 
    	  
	  	  	 	(Name of Disclosed Principal) 	 
    
	 
    	  	 	  	  
	(SSN or
      other Tax Identification Number of the Subscriber) 	 	 
    	  
	  	  	 	(Address of Disclosed Principal) 	 
    
	 
    	  	 	  	  
	(Subscriber’s Address, including city and state of residence)
	 	 
    	  
	  	  	 	  	  
	 
    	  	 	  	  
	  	  	 	(SSN or other Tax Identification Number of Disclosed Principal)
    
	 
    	  	 	  	  
	(Telephone Number) 	(Email Address) 	 	 
    	  
	  	  	 	  	  
	Register the Shares and Warrants as set forth
      below: 	 	Deliver the Shares and Warrants as set forth
      below: 
	 
    	  	 	  	  
	(Name to Appear on
      Share and Warrant Certificate) 	  	 	(Name) 	 
    
	  	  	 	  	  
	  	 
    	 	(Address) 	 
    
	(Address, including
      Postal Code) 	  	 	 
    	  
	 
    	  	 	  	  
	  	  	 	(Contact Name) 	(Telephone Number) 
	 
    	  	 	  	  
	 
    	  	 	  	  
	Number
      and kind of securities of the Company held, directly or 	 	  	  
	indirectly, or over which control or direction is exercised
      by the 	 	  	  
	Subscriber, if
      any: 	  	 	  	  
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 

ACCEPTANCE: The Company hereby accepts the subscription as set
forth above on the terms and conditions contained in this Subscription
Agreement. 

	THE ALKALINE WATER COMPANY INC. 	_________________________, 2016

	Per: 	 
		Authorized Signatory

TERMS AND CONDITIONS OF SUBSCRIPTION FOR UNITS 

	1. 	
      Subscription

1.1          
On the basis of the representations and warranties and subject to the terms and
conditions set forth herein, the undersigned (the “Subscriber”) hereby
irrevocably subscribes for and agrees to purchase such number of Units as is set
forth on page 2 of this subscription agreement (the “Agreement”) at a
price of US$♦ per Unit for the Subscription Amount, as set forth
on page 2 of the Agreement, which is tendered herewith (such subscription and
agreement to purchase being the “Subscription”). 

1.2          
Each Unit will consist of one Share and one-third of one Warrant. Each Warrant
will entitle the holder thereof to purchase one Warrant Share, as presently
constituted, for a period of 24 months commencing from the Closing Date at an
exercise price of US$♦ per Warrant Share. The Units, Shares, Warrants and
Warrant Shares are referred to herein as the “Securities”. 

1.3          
The Company hereby agrees to sell the Units to the Subscriber on the basis of
the representations and warranties and subject to the terms and conditions set
forth in this Agreement. Subject to the terms of this Agreement, this Agreement
will be effective upon its acceptance by the Company.

1.4          
The Subscriber acknowledges that the Subscriber has received the prospectus (the
“Prospectus”) describing the offering (the “Offering”) of the
Units by the Company as filed with the United States Securities and Exchange
Commission. 

1.5          
Unless otherwise provided, all dollar amounts referred to in this Agreement are
in lawful money of the United States. 

	2. 	
      Payment

2.1          
The Subscription Amount must accompany this Subscription and shall be paid by
certified cheque or bank draft drawn on a bank in the United States reasonably
acceptable to the Company, and made payable and delivered to the Company.
Alternatively, the Subscription Amount may be wired to the Company or its
lawyers pursuant to wiring instructions provided by the Company or its lawyers.
If the funds are wired to the Company’s lawyers, the Subscriber authorizes such
lawyers to immediately deliver the funds to the Company upon receipt of the
funds from the Subscriber. The Subscriber authorizes the Company to treat the
Subscription Amount as an interest free loan until the closing of the Offering
(the “Closing”). 

2.2          
The Subscriber acknowledges and agrees that this Agreement, the Subscription
Amount and any other documents delivered in connection herewith will be held on
behalf of the Company. In the event that this Agreement is not accepted by the
Company for whatever reason, which the Company expressly reserves the right to
do, the Subscription Amount (without interest thereon) and any other documents
delivered in connection herewith will be returned to the Subscriber at the
address of the Subscriber as set forth on page 2 of this Agreement. 

	3. 	
      Documents Required from
  Subscriber

3.1          
The Subscriber must complete, sign and return to the Company the following
documents: 

	 	(a) 	
      an executed copy of this Agreement; and

	 	 	 
	 	(b) 	
      if the Subscriber is a U.S. Purchaser (as defined in
      Exhibit A), an Accredited Investor Questionnaire (the
      “Questionnaire”) attached as Exhibit “A”
hereto.

3.2          
The Subscriber shall complete, sign and return to the Company as soon as
possible, on request by the Company, any additional documents, questionnaires,
notices and undertakings as may be required by any regulatory authorities and
applicable law. 

- 4 - 

3.3          
Both parties to this Agreement acknowledge and agree that Clark Wilson LLP has
acted as counsel only to the Company and is not protecting the rights and
interests of the Subscriber. The Subscriber acknowledges and agrees that the
Company and Clark Wilson LLP have given the Subscriber the opportunity to seek,
and have recommended that the Subscriber obtain, independent legal advice with
respect to the subject matter of this Agreement and, further, the Subscriber
hereby represents and warrants to the Company and Clark Wilson LLP that the
Subscriber has sought independent legal advice or waives such advice.

	4. 	
      Conditions and
Closing

4.1          
The Closing shall occur on a date to be determined by the Company in its sole
discretion (the “Closing Date”), provided that the Closing Date is on or
prior to ♦, 2016. The Company may, at its discretion, elect to close the
Offering in one or more closings, in which event the Company may agree with one
or more subscribers (including the Subscriber to this Agreement) to complete
delivery of the Shares and Warrants to such subscriber(s) against payment
therefor at any time on or prior to the Closing Date. 

	5. 	
      Acknowledgements and Agreements of
      Subscriber

5.1          
The Subscriber acknowledges and agrees that: 

	 	(a) 	
      the decision to acquire the Securities will not be based
      upon any oral representation as to fact or otherwise made by or on behalf
      of the Company and such decision will be based entirely upon a review of
      the Prospectus;

	 	 	 
	 	(b) 	
      there are risks associated with an investment in the
      Securities;

	 	 	 
	 	(c) 	
      all of the information which the Subscriber has provided
      to the Company is correct and complete as of the date this Agreement is
      signed, and if there should be any change in such information prior to
      this Agreement being executed by the Company, the Subscriber will
      immediately provide the Company with such information;

	 	 	 
	 	(d) 	
      the Company is entitled to rely on the representations
      and warranties of the Subscriber contained in this Agreement and, if
      applicable, the Questionnaire and the Subscriber will hold harmless the
      Company from any loss or damage it or they may suffer as a result of the
      Subscriber’s failure to correctly complete this Agreement or, if
      applicable, the Questionnaire;

	 	 	 
	 	(e) 	
      the Subscriber will indemnify and hold harmless the
      Company and, where applicable, its directors, officers, employees, agents,
      advisors and shareholders, from and against any and all loss, liability,
      claim, damage and expense whatsoever (including, but not limited to, any
      and all fees, costs and expenses whatsoever reasonably incurred in
      investigating, preparing or defending against any claim, lawsuit,
      administrative proceeding or investigation whether commenced or
      threatened) arising out of or based upon any representation or warranty of
      the Subscriber contained in this Agreement, if applicable, the
      Questionnaire or in any document furnished by the Subscriber to the
      Company in connection herewith being untrue in any material respect or any
      breach or failure by the Subscriber to comply with any covenant or
      agreement made by the Subscriber to the Company in connection
      therewith;

	 	 	 
	 	(f) 	
      the Subscriber has been advised to consult the
      Subscriber’s own legal, tax and other advisors with respect to the merits
      and risks of an investment in the Securities and with respect to
      applicable resale restrictions, and it is solely responsible (and the
      Company is not in any way responsible) for compliance
  with:

	 	(i) 	
      any applicable laws of the jurisdiction in which the
      Subscriber is resident in connection with the distribution of the
      Securities hereunder, and

	 	 	 
	 	(ii) 	
      applicable resale
restrictions;

- 5 - 

	 	(g) 	
      the Company will refuse to register the transfer any of
      the Securities not made pursuant to an effective registration statement
      under the 1933 Act or pursuant to an available exemption from the
      registration requirements of the 1933 Act and in each case in accordance
      with applicable securities laws;

	 	 	 
	 	(h) 	
      no securities commission or similar regulatory authority
      has reviewed or passed on the merits of any of the Securities;

	 	 	 
	 	(i) 	
      there is no government or other insurance covering any of
      the Securities;

	 	 	 
	 	(j) 	
      by execution hereof, the Subscriber has waived the need
      for the Company to communicate its acceptance of the purchase of the Units
      pursuant to this Agreement; and

	 	 	 
	 	(k) 	
      this Agreement is not enforceable by the Subscriber
      unless it has been accepted by the Company, and the Subscriber
      acknowledges and agrees that the Company reserves the right to reject any
      Subscription for any reason whatsoever.

	6. 	
      Representations, Warranties and Covenants of the
      Subscriber

6.1          
The Subscriber hereby represents and warrants to and covenants with the Company
(which representations, warranties and covenants shall survive the Closing)
that: 

	 	(a) 	
      unless the Subscriber has completed Exhibit “A”, the
      Subscriber is not a U.S. Person;

	 	 	 
	 	(b) 	
      the Subscriber is resident in the jurisdiction shown as
      the “Subscriber’s Address” on page 2 of this Agreement;

	 	 	 
	 	(c) 	
      if the Subscriber is resident outside of the United
      States:

	 	(i) 	
      the Subscriber is knowledgeable of, or has been
      independently advised as to, the applicable securities laws having
      application in the jurisdiction in which the Subscriber is resident (the
      “International Jurisdiction”) which would apply to the offer and
      sale of the Securities,

	 	 	 
	 	(ii) 	
      the Subscriber is purchasing the Securities pursuant to
      exemptions from prospectus or equivalent requirements under applicable
      securities laws of the International Jurisdiction or, if such is not
      applicable, the Subscriber is permitted to purchase the Securities under
      applicable securities laws of the International Jurisdiction without the
      need to rely on any exemptions,

	 	 	 
	 	(iii) 	
      the applicable securities laws of the International
      Jurisdiction do not require the Company to make any filings or seek any
      approvals of any kind from any securities regulator of any kind in the
      International Jurisdiction in connection with the offer, issue, sale or
      resale of any of the Securities,

	 	 	 
	 	(iv) 	
      the purchase of the Securities by the Subscriber does not
      trigger:

	 	A. 	
      any obligation to prepare and file a prospectus or
      similar document, or any other report with respect to such purchase in the
      International Jurisdiction, or

	 	 	 
	 	B. 	
      any continuous disclosure reporting obligation of the
      Company in the International Jurisdiction, and

	 	(v) 	
      the Subscriber will, if requested by the Company, deliver
      to the Company a certificate or opinion of local counsel from the
      International Jurisdiction which will confirm
the matters referred to in subparagraphs (ii), (iii) and (iv) above
to the satisfaction of the Company, acting reasonably; 

- 6 - 

	 	(d) 	
      the Subscriber has the legal capacity and competence to
      enter into and execute this Agreement and to take all actions required
      pursuant hereto and, if the Subscriber is a corporate entity, it is duly
      incorporated and validly subsisting under the laws of its jurisdiction of
      incorporation and all necessary approvals by its directors, shareholders
      and others have been obtained to authorize execution and performance of
      this Agreement on behalf of the Subscriber;

	 	 	 
	 	(e) 	
      the entering into of this Agreement and the transactions
      contemplated hereby do not result in the violation of any of the terms and
      provisions of any law applicable to, or the constating documents of, the
      Subscriber or of any agreement, written or oral, to which the Subscriber
      may be a party or by which the Subscriber is or may be bound;

	 	 	 
	 	(f) 	
      the Subscriber has duly executed and delivered this
      Agreement and it constitutes a valid and binding agreement of the
      Subscriber enforceable against the Subscriber;

	 	 	 
	 	(g) 	
      the Subscriber has received and carefully read this
      Agreement and the Prospectus;

	 	 	 
	 	(h) 	
      the Subscriber is aware that an investment in the Company
      is speculative and involves certain risks (including those risks disclosed
      in the Prospectus), including the possible loss of the entire
      investment;

	 	 	 
	 	(i) 	
      the Subscriber understands and agrees that the Company
      and others will rely upon the truth and accuracy of the acknowledgements,
      representations, warranties, covenants and agreements contained in this
      Agreement and, if applicable, the Questionnaire and agrees that if any of
      such acknowledgements, representations and agreements are no longer
      accurate or have been breached, the Subscriber shall promptly notify the
      Company;

	 	 	 
	 	(j) 	
      the Subscriber is not an underwriter of, or dealer in,
      the Securities, nor is the Subscriber participating, pursuant to a
      contractual agreement or otherwise, in the distribution of the
      Securities;

	 	 	 
	 	(k) 	
      the Subscriber understands and agrees that there may be
      material tax consequences to the Subscriber of an acquisition or
      disposition of the Securities. The Company gives no opinion and makes no
      representation with respect to the tax consequences to the Subscriber
      under federal, state, local or foreign tax law of the Subscriber’s
      acquisition or disposition of the Securities;

	 	 	 
	 	(l) 	
      no person has made to the Subscriber any written or oral
      representations:

	 	(i) 	
      that any person will resell or repurchase any of the
      Securities,

	 	 	 
	 	(ii) 	
      that any person will refund the purchase price of any of
      the Securities, or

	 	 	 
	 	(iii) 	
      as to the future price or value of any of the Securities,
      or

	 	 	 
	 	(iv) 	
      that any of the Securities will be listed and posted for
      trading on any stock exchange or automated dealer quotation system or that
      application has been made to list and post any of the Securities on any
      stock exchange or automated dealer quotation system, except that certain
      market makers make market in the Company’s shares of common stock on the
      OTCQB marketplace operated by the OTC Markets Group,
and

	 	(m) 	
      the Subscriber acknowledges and agrees that the Company
      shall not consider the Subscriber’s Subscription for acceptance unless the
      Subscriber provides to the Company, along with an executed copy of this
      Agreement:

- 7 - 

	 	(i) 	
      if the Subscriber is a U.S. Purchaser (as defined in
      Exhibit “A”), fully completed and executed Questionnaire in the form
      attached hereto as Exhibit “A”; and

	 	 	 
	 	(ii) 	
      such other supporting documentation that the Company or
      its legal counsel may request to establish the Subscriber’s qualification
      as a qualified investor.

6.2          
In this Agreement and the Questionnaire, the term “U.S. Person” shall have the
meaning ascribed thereto in Regulation S promulgated under the 1933 Act and for
the purpose of this Agreement includes any person in the United States. 

	7. 	
      Representations and Warranties will be Relied Upon
      by the Company

7.1          
The Subscriber acknowledges that the representations and warranties contained
herein are made by the Subscriber with the intention that such representations
and warranties may be relied upon by the Company and its legal counsel in
determining the Subscriber’s eligibility to purchase the Securities under
applicable securities laws, or (if applicable) the eligibility of others on
whose behalf the Subscriber is contracting hereunder to purchase the Securities
under applicable securities laws. The Subscriber further agrees that by
accepting delivery of the certificates representing the Securities on the
Closing Date, it will be representing and warranting that the representations
and warranties contained herein are true and correct as at the Closing Date with
the same force and effect as if they had been made by the Subscriber on the
Closing Date and that they will survive the purchase by the Subscriber of the
Securities and will continue in full force and effect notwithstanding any
subsequent disposition by the Subscriber of such Securities. 

	8. 	
      Waiver

8.1          
The Subscriber hereby waives, to the fullest extent permitted by law, any rights
of withdrawal, rescission or compensation for damages to which the Subscriber
might be entitled in connection with the distribution of any of the Securities.

	9. 	
      Collection of Personal
  Information

9.1          
The Subscriber acknowledges and consents to the fact that the Company is
collecting the Subscriber’s personal information for the purpose of fulfilling
this Agreement and completing the Offering. The Subscriber’s personal
information (and, if applicable, the personal information of those on whose
behalf the Subscriber is contracting hereunder) may be disclosed by the Company
to (a) stock exchanges or securities regulatory authorities, (b) the Company’s
registrar and transfer agent, (c) tax authorities and any other governmental
authorities and (d) any of the other parties involved in the Offering, including
legal counsel, and may be included in record books in connection with the
Offering. By executing this Agreement, the Subscriber is deemed to be consenting
to the collection, use and disclosure of the Subscriber’s personal information
(and, if applicable, the personal information of those on whose behalf the
Subscriber is contracting hereunder) for the foregoing purposes, and to the
retention of such personal information for as long as permitted or required by
law or business practice. Notwithstanding that the Subscriber may be purchasing
Securities as agent on behalf of an undisclosed principal, the Subscriber agrees
to provide, on request, particulars as to the identity of such undisclosed
principal as may be required by the Company in order to comply with the
foregoing. 

	10. 	
      Costs

10.1          
The Subscriber acknowledges and agrees that all costs and expenses incurred by
the Subscriber (including any fees and disbursements of any special counsel
retained by the Subscriber) relating to the purchase of the Securities shall be
borne by the Subscriber. 

	11. 	
      Execution of Subscription
  Agreement

11.1          
The Company shall be entitled to rely on delivery by facsimile machine or e-mail
of an executed copy of this Agreement, and acceptance by the Company of such
facsimile or e-mail copy shall be equally effective to create a valid and binding agreement between the Subscriber
and the Company in accordance with the terms hereof. If less than a complete
copy of this Agreement is delivered to the Company at Closing, the Company and
its counsel are entitled to assume that the Subscriber accepts and agrees to all
of the terms and conditions of the pages not delivered at Closing unaltered.
This Agreement may be executed in two or more counterparts, each of which shall
be deemed to be an original and all of which together shall constitute one and
the same Agreement.

- 8 - 

11.2          
The Subscriber hereby authorizes the Company to correct any minor errors in, or
complete any minor information missing from any part of this Agreement and any
other acknowledgements, provisions, forms, certificates or documents executed by
the Subscriber and delivered to the Company in connection with the Subscription.

	12. 	
      Beneficial
Subscribers

12.1          
Whether or not explicitly stated in this Agreement, any acknowledgement,
representation, warranty, covenant or agreement made by the Subscriber in this
Subscription Agreement, including the exhibits hereto, will be treated as if
made by the disclosed beneficial subscriber, if any. 

	13. 	
      Governing Law

13.1          
This Agreement is governed by the laws of the State of Nevada and the federal
laws of the United States applicable therein. The Subscriber, in its personal or
corporate capacity and, if applicable, on behalf of each beneficial purchaser
for whom it is acting, irrevocably attorns to the jurisdiction of the courts of
the State of Arizona. 

	14. 	
      Survival

14.1          
This Agreement, including, without limitation, the representations, warranties
and covenants contained herein, shall survive and continue in full force and
effect and be binding upon the parties hereto notwithstanding the completion of
the purchase of the Securities by the Subscriber pursuant hereto. 

	15. 	
      Severability

15.1          
The invalidity or unenforceability of any particular provision of this Agreement
shall not affect or limit the validity or enforceability of the remaining
provisions of this Agreement. 

	16. 	
      Entire Agreement

16.1          
Except as expressly provided in this Agreement and in the agreements,
instruments and other documents contemplated or provided for herein, this
Agreement contains the entire agreement between the parties with respect to the
sale of the Units and there are no other terms, conditions, representations or
warranties, whether expressed, implied, oral or written, by statute or common
law, by the Company or by anyone else. 

	17. 	
      Notices

17.1          
All notices and other communications hereunder shall be in writing and shall be
deemed to have been duly given if mailed or transmitted by any standard form of
telecommunication. Notices to the Subscriber shall be directed to the address of
the Subscriber set forth on page 2 of this Agreement and notices to the Company
shall be directed to it at 7730 E Greenway Road, Ste. 203, Scottsdale, Arizona
85260, Attention: President. 

- 9 - 

	18. 	
      Counterparts and Electronic
  Means

18.1          
This Agreement may be executed in any number of counterparts, each of which,
when so executed and delivered, shall constitute an original and all of which
together shall constitute one instrument. Delivery of an executed copy of this
Agreement by electronic facsimile transmission or other means of electronic
communication capable of producing a printed copy will be deemed to be
execution and delivery of this Agreement as of the date hereinafter set forth.

- 10 - 

EXHIBIT A 

ACCREDITED INVESTOR QUESTIONNAIRE 

All capitalized terms herein, unless otherwise defined, have
the meanings ascribed thereto in the Subscription Agreement between The Alkaline
Water Company Inc. (the “Company”) and the undersigned Subscriber.

This Questionnaire applies only to persons that are U.S.
Purchasers. A “U.S. Purchaser” is: (a) any U.S. Person, (b) any person
purchasing the Units on behalf of any U.S. Person, (c) any person that receives
or received an offer of the Units while in the United States, or (d) any person
that is in the United States at the time the Subscriber’s buy order was made or
this Agreement was executed or delivered.

The purpose of this Questionnaire is to assure the Company that
the Subscriber will meet the standards imposed by the appropriate exemptions of
applicable state securities laws. The Company will rely on the information
contained in this Questionnaire for the purposes of such determination. This
Questionnaire is not an offer of the Securities or any other securities of the
Company in any state other than those specifically authorized by the Company.

By signing and returning this Questionnaire, the Subscriber
agrees that, if necessary, this Questionnaire may be presented to such parties
as the Company deems appropriate to establish the availability, under applicable
state securities law, of an exemption from registration in connection with the
sale of the Securities hereunder. 

The Subscriber covenants, represents and warrants to the
Company that it satisfies one or more of the categories of “Accredited
Investors”, as defined by Regulation D promulgated under the United States
Securities Act of 1933 (the “1933 Act”), as indicated below: (Please
initial in the space provide those categories, if any, of an “Accredited
Investor” which the Subscriber satisfies) 

          Category
1      An organization described in Section
501(c)(3) of the United States Internal Revenue Code, a corporation, a
Massachusetts or similar business trust or partnership, not formed for the
specific purpose of acquiring the Securities, with total assets in excess of
US$5,000,000; 

          Category
2      A natural person whose individual net
worth, or joint net worth with that person’s spouse, exceeds US$1,000,000. For
purposes of this Category 2, "net worth" means the excess of total assets at
fair market value (including personal and real property, but excluding the
estimated fair market value of a person's primary home) over total liabilities.
Total liabilities excludes any mortgage on the primary home in an amount of up
to the home's estimated fair market value as long as the mortgage was incurred
more than 60 days before the Securities are acquired, but includes (i) any
mortgage amount in excess of the home's fair market value and (ii) any mortgage
amount that was borrowed during the 60-day period before the date of the
acquisition of Securities for the purpose of investing in the Securities; 

          Category
3      A natural person who had an individual
income in excess of US$200,000 in each of the two most recent years or joint
income with that person’s spouse in excess of US$300,000 in each of those years
and has a reasonable expectation of reaching the same income level in the
current year; 

____ Category
4      A “bank” as defined under Section (3)(a)(2)
of the 1933 Act or savings and loan association or other institution as defined
in Section 3(a)(5)(A) of the 1933 Act acting in its individual or fiduciary
capacity; a broker dealer registered pursuant to Section 15 of the Securities
Exchange Act of 1934 (United States); an insurance company as defined in
Section 2(13) of the 1933 Act; an investment company registered under the
Investment Company Act of 1940 (United States) or a business development
company as defined in Section 2(a)(48) of such Act; a Small Business Investment
Company licensed by the U.S. Small Business Administration under Section 301(c)
or (d) of the Small Business Investment Act of 1958 (United States); a
plan with total assets in excess of US$5,000,000 established and maintained by a
state, a political subdivision thereof, or an agency or instrumentality of a
state or a political subdivision thereof, for the benefit of its employees; an
employee benefit plan within the meaning of the Employee Retirement Income
Security Act of 1974 (United States) whose investment decisions are made by
a plan fiduciary, as defined in Section 3(21) of such Act, which is either a bank,
savings and loan association, insurance company or registered investment
adviser, or if the employee benefit plan has total assets in excess of
US$5,000,000, or, if a self-directed plan, whose investment decisions are made
solely by persons that are accredited investors; 

- 11 - 

____ Category
5           A private
business development company as defined in Section 202(a)(22) of the
Investment Advisers Act of 1940 (United States); 

          Category
6           A director or
executive officer of the Company; 

____ Category
7          A trust with total
assets in excess of US$5,000,000, not formed for the specific purpose of
acquiring the Securities, whose purchase is directed by a sophisticated person
as described in Rule 506(b)(2)(ii) under the 1933 Act; 

____ Category
8          An entity in which all
of the equity owners satisfy the requirements of one or more of the foregoing
categories; 

Note that the Subscriber claiming to satisfy one of the above
categories of Accredited Investor may be required to supply the Company with a
balance sheet, prior years’ federal income tax returns or other appropriate
documentation to verify and substantiate the Subscriber’s status as an
Accredited Investor. 

If the Subscriber is an entity which initialled Category 8 in
reliance upon the Accredited Investor categories above, state the name, address,
total personal income from all sources for the previous calendar year, and the
net worth (exclusive of home, home furnishings and personal automobiles) for
each equity owner of the said entity:

	 
	 

The Subscriber hereby certifies that the information contained
in this Questionnaire is complete and accurate and the Subscriber will notify
the Company promptly of any change in any such information. If this
Questionnaire is being completed on behalf of a corporation, partnership, trust
or estate, the person executing on behalf of the Subscriber represents that it
has the authority to execute and deliver this Questionnaire on behalf of such
entity. 

IN WITNESS WHEREOF, the undersigned has executed this
Questionnaire as of the ____ day of ________________, 2016. 

	 	Print or
      Type Name of Entity 
	 	 
	 	Signature of Authorized Signatory 
	 	 
	 	Type of EntityExhibit

8 JANUARY 2016
------------
SETTLEMENT AGREEMENT

between

HOLOGIC  IP  LTD
HOLOGIC, INC.

and

CLAUS EGSTRAND

CONTENTS

CLAUSE
	
				
	1.
	Interpretation
	1
	

	2.
	Arrangements on termination
	3
	

	3.
	Termination payments
	3
	

	4.
	Benefits
	4
	

	5.
	Equity Plan
	4
	

	6.
	Legal fees
	4
	

	7.
	Waiver of claims
	5
	

	8.
	Employee indemnities
	6
	

	9.
	Company property and information
	7
	

	10.
	Employee warranties and acknowledgments
	7
	

	11.
	Employer warranty and acknowledgment
	8
	

	12.
	Resignation from offices
	8
	

	13.
	Confidentiality and other post termination obligations
	8
	

	14.
	Confidentiality of agreement and no derogatory statements
	9
	

	15.
	Entire agreement
	9
	

	16.
	Variation
	10
	

	17.
	Third party rights
	10
	

	18.
	Governing law
	11
	

	19.
	Jurisdiction
	11
	

	20.
	Subject to contract and without prejudice
	11
	

	21.
	Counterparts
	11
	

SCHEDULE
	
				
	SCHEDULE 1:
	CLAIMS
	12
	

	SCHEDULE 2:
	ADVISER’S CERTIFICATE
	15
	

	SCHEDULE 3:
	RESIGNATION
	16
	

	 
	 
	 

	 
	 
	 

	 
	 
	 

	 
	 
	 

	 
	 
	 

	 
	 
	 

	 
	 
	 

THIS  AGREEMENT is dated January 8, 2016.
PARTIES
		
	(1)
	Hologic IP Ltd  incorporated in England and Wales (company number 09484129),  whose registered office is at Heron House, Oaks Business Park, Crewe Road, Wythenshawe, Manchester M23 9HZ, United Kingdom (Employer)

		
	(2)
	Hologic, Inc. incorporated and registered in the United States of America whose registered office is at 250 Campus Drive, Marlborough, Massachusetts 01752, United States of America (Hologic, Inc).

		
	(3)
	Claus Egstrand of 17 Chisholm Road, Richmond, Surrey, TW10 6JH, United Kingdom (Employee).

(together the Parties)
BACKGROUND
		
	(A)
	The Employee is employed by the Employer as Group President, International, and entered a Service Agreement dated 5 March 2014 (the Service Agreement).

		
	(B)
	The Employee's employment with the Employer shall terminate on January 8, 2016.

		
	(C)
	A Severance and Change of Control Agreement dated 18 September 2014 and made between Hologic, Inc. and the Employee (the SCoC Agreement) provides for certain payments to be made to the Employee on termination of his employment in certain circumstances.

		
	(D)
	The Parties have entered into this agreement to record and implement the terms on which they have agreed to settle any claims that the Employee has or may have in connection with his employment or its termination or otherwise against the Employer and/or Hologic, Inc. whether or not those claims are, or could be, in the contemplation of the parties at the time of signing this agreement.

		
	(E)
	The parties intend this agreement to be an effective waiver of any such claims and to satisfy the conditions relating to settlement agreements in the Relevant Legislation.

		
	(F)
	The Employer enters into this agreement for itself and as agent and trustee for all Group Companies and it is authorised to do so. It is the Parties' intention that each Group Company should be able to enforce any rights it has under this agreement, subject to and in accordance with the Contracts (Rights of Third Parties) Act 1999.

AGREED TERMS
		
	1.
	INTERPRETATION

The following definitions and rules of interpretation apply in this agreement.
		
	1.1
	Definitions:

1

Adviser: Kathryn Coyle of Kidd Rapinet instructed to represent the Employee in relation to this agreement.
Confidential Information: information in whatever form (including, without limitation, in written, oral, visual or electronic form or on any magnetic or optical disk or memory and wherever located) relating to the business, products, affairs and finances of the Employer for the time being confidential to the Employer and trade secrets including, without limitation, technical data and know-how relating to the business of the Employer or any of its suppliers, clients, customers, agents, distributors, shareholders or management, including (but not limited to) information that the Employee created, developed, received or obtained in connection with his employment, whether or not such information (if in anything other than oral form) is marked confidential.
Copies: copies or records of any Confidential Information in whatever form (including, without limitation, in written, oral, visual or electronic form or on any magnetic or optical disk or memory and wherever located) including, without limitation, extracts, analysis, studies, plans, compilations or any other way of representing or recording and recalling information which contains, reflects or is derived or generated from Confidential Information.
Group Company: the Employer, Hologic, Inc., their Subsidiaries or Holding Companies from time to time and any Subsidiary of any Holding Company from time to time.
Subsidiary and Holding Company:  in relation to a company mean "subsidiary" and "holding company" as defined in section 1159 of the Companies Act 2006.
Relevant Legislation: section 147(3) of the Equality Act 2010, section 288(2B) of the Trade Union and Labour Relations (Consolidation) Act 1992, section 203(3) of the Employment Rights Act 1996, regulation 35(3) of the Working Time Regulations 1998, section 49(4) of the National Minimum Wage Act 1998, regulation 41(4) of the Transnational Information and Consultation etc. Regulations 1999, regulation 9 of the Part-Time Workers (Prevention of Less Favourable Treatment) Regulations 2000, regulation 10 of the Fixed-Term Employees (Prevention of Less Favourable Treatment) Regulations 2002, regulation 40(4) of the Information and Consultation of Employees Regulations 2004, paragraph 13 of the Schedule to the Occupational and Personal Pension Schemes (Consultation by Employers and Miscellaneous Amendment) Regulations 2006, regulation 18 of the Transfer of Undertakings (protection of Employment) Regulations 2006, regulation 62 of the Companies (Cross Border Mergers) Regulations 2007 and section 58 of the Pensions Act 2008.
		
	1.2
	The headings in this agreement are inserted for convenience only and shall not affect its construction.

2

		
	1.3
	A reference to a particular law is a reference to it as it is in force for the time being taking account of any amendment, extension, or re-enactment and includes any subordinate legislation for the time being in force made under it.

		
	1.4
	The Schedules shall form part of this agreement and shall have effect as if set out in full in the body of this agreement. Any reference to this agreement includes the Schedules.

		
	2.
	ARRANGEMENTS ON TERMINATION

		
	2.1
	The Employee's employment with the Employer shall terminate on January 8, 2016   (Termination Date).

		
	2.2
	The Employer shall pay the Employee his salary up to and including the Termination Date in the usual way.

		
	2.3
	The Employer shall continue to provide benefits to the Employee in the usual way up to and including the Termination Date.

		
	2.4
	The Employer shall make a payment to the Employee in respect of six days' outstanding holiday amounting to £6,417.69 up to and including the Termination Date. 

		
	2.5
	The payments and benefits in this clause 2 shall be subject to the income tax and National Insurance contributions that the Employer is obliged by law to pay or deduct.

		
	2.6
	The Employee shall submit on or before January 22, 2016 his expenses claims in the usual way and the Employer shall reimburse the Employee for any expenses properly incurred before the Termination Date in the usual way. 

		
	3.
	TERMINATION PAYMENTS

		
	3.1
	Subject to and conditional on the Employee complying with the terms of this agreement and subject to receipt by the Employer of a copy of this agreement signed by the Employee and a letter from the Adviser in the form as set out in Schedule 2, no later than January 8, 2016 (the  Payment Conditions), the Employer shall, without admission of liability on its or Hologic, Inc.'s behalf (in particular but not limited to whether or not the Employee is entitled to any payment under the SCoC Agreement) pay to the Employee:

		
	3.1.1
	the sum of £545,926.50, representing Base Salary and Average Annual Bonus calculated as  per 6 (e)(iii) of the SCoC Agreement  (Termination Payment), payable in twelve equal monthly instalments; and

		
	3.1.2 
	a pro rata bonus of £93,771.81 for the financial year 27 September 2015 to 24 September 2016 calculated up to the Termination Date (the pro rata Bonus);   

3

The first instalment of the Termination Payment will be paid within 14 days of the Termination Date or fulfilment of the Payment Conditions, whichever is the later and the remaining instalments will be made on or about the last working day of each month following the month in which the first instalment is paid.  The pro rata Bonus will be paid within 30 days of the Termination Date or fulfilment of the Payment Conditions, whichever is later.
		
	3.2
	The Termination Payment and the pro rata Bonus will be paid less deductions for tax and National Insurance Contributions (NICs) at the applicable rates. The Employee shall be responsible for any further tax and employee's National Insurance contributions due in respect of all payments made hereunder and shall indemnify the Employer in respect of such liability in accordance with clause 8.1. 

		
	4.
	BENEFITS 

Subject to and conditional on the Employee complying with the terms of this agreement, the Employer shall, within 30 days of the Termination Date, make a one-time, lump-sum payment to Employee of £2,442, which payment shall be made in lieu of continued medical and dental benefits.  The Employee shall be responsible for any tax and employee's NICs due in respect of this payment.  All other benefits, save as expressly provided herein will cease with effect from the Termination Date
		
	5.
	EQUITY PLAN

		
	5.1
	All outstanding, unvested equity awards issued to the Employee shall be cancelled and forfeited as of the Termination Date and all vested equity awards shall be exercisable in accordance with the terms of the governing award agreement and plan.

		
	6.
	LEGAL FEES

The Employer shall pay the reasonable legal fees (up to a maximum of £2,500 plus VAT) incurred by the Employee in obtaining advice on the termination of his employment and the terms of this agreement, such fees to be payable to the Adviser on production of an invoice, addressed to the Employee but marked payable by the Employer.
		
	7.
	WAIVER OF CLAIMS

		
	7.1
	The Employee agrees that the terms of this agreement are offered by the Employer without any admission of liability on the part of the Employer and/or Hologic, Inc. and are in full and final settlement of all and any claims or rights of action that the Employee has or may have against the Employer, Hologic, Inc., any other Group Company or the officers or employees of  any of them, whether arising out of his employment with the Employer or its termination or from events occurring after this agreement has been 

4

entered into, whether under common law, contract, statute or otherwise, whether such claims are, or could be, known to the parties or in their contemplation at the date of this agreement in any jurisdiction and including, but not limited to, the claims specified in Schedule 1 (each of which is waived by this clause).
		
	7.2
	The waiver in clause 7.1 shall not apply to the following:

7.2.1    any claims by the Employee to enforce this agreement;
		
	7.2.2
	claims in respect of personal injury of which the Employee is not aware and could not reasonably be expected to be aware at the date of this agreement  (other than claims under discrimination legislation); and 

		
	7.3
	The Employee warrants that:

		
	7.3.1
	before entering into this agreement he received independent advice from the Adviser as to the terms and effect of this agreement and, in particular, on its effect on his ability to pursue any complaint before an employment tribunal or other court;

		
	7.3.2
	the Adviser has confirmed to the Employee that he/she is a lawyer holding a current practising certificate and that there is in force a policy of insurance covering the risk of a claim by the Employee in respect of any loss arising in consequence of his/her advice;

		
	7.3.3
	the Adviser shall sign and deliver to the Employer a letter in the form attached as to this agreement;

		
	7.3.4
	before receiving the advice the Employee disclosed to the Adviser all facts and circumstances that may give rise to a claim by the Employee against the Employer or its officers or employees;

		
	7.3.5
	the only claims that the Employee has or may have against the Employer, Hologic, Inc. or the officers or employees of either of them (whether at the time of entering into this agreement or in the future) relating to his employment with the Employer or its termination are specified in clause 7.1.  

		
	7.4
	The Employee acknowledges that the Employer and Hologic, Inc. acted in reliance on these warranties when entering into this Settlement Agreement.

		
	7.5
	The Employee acknowledges that the conditions relating to settlement agreements under the Relevant Legislation have been satisfied.

		
	7.6
	The waiver in clause 7.1 shall have effect irrespective of whether or not, at the date of this agreement, the Employee is or could be aware of such claims or have such claims 

5

in his express contemplation (including such claims of which the Employee becomes aware after the date of this agreement in whole or in part as a result of new legislation or the development of common law or equity).
		
	7.7
	The Employee agrees that, except for the payments and benefits provided for in this agreement, and subject to the waiver in clause 7.1, he shall not be eligible for any further payment from the Employer relating to his employment or its termination and without limitation to the generality of the foregoing, he expressly waives any right or claim that he has or may have to payment of bonuses, any benefit or award programme, under any share plan operated by the Employer, Hologic, Inc. or any other Group Company or any stand-alone share incentive arrangement, or to any other benefit, payment or award he may have received had his employment not terminated.

		
	8.
	EMPLOYEE INDEMNITIES

		
	8.1
	The Employee shall indemnify the Employer and Hologic, Inc. on a continuing basis in respect of any income tax or NICs (or similar) (save, where prohibited by law, for employers' National Insurance contributions) due in respect of the payments and benefits in clause 3.1 and clause 4 (and any related interest, penalties, costs and expenses). The Employer shall give the Employee reasonable notice of any demand for tax which may lead to liabilities on the Employee under this indemnity and shall provide him with reasonable access to any documentation he may reasonably require to dispute such a claim (provided that nothing in this clause shall prevent the Employer from complying with its legal obligations with regard to HM Revenue and Customs or other competent body).

		
	8.2
	If the Employee breaches any material provision of this agreement or pursues a claim against the Employer arising out of his employment or its termination other than those excluded under clause 7, he agrees to indemnify the Employer for any losses suffered as a result thereof, including all reasonable legal and professional fees incurred.

		
	9.
	COMPANY PROPERTY AND INFORMATION

		
	9.1
	The Employee shall, before the Termination Date, return to Mark Scuzzarella, Vice President, Human Resources:

		
	(a)
	all Confidential Information and Copies;

		
	(b)
	all property belonging to the Employer, Hologic, Inc. or any other Group Company in satisfactory condition including (but not limited to) any car (together with the keys and all documentation relating to the car) , fuel card, company credit card, keys, security pass, identity badge, mobile telephone, pager, lap-top computer or fax machine; and

6

		
	(c)
	all documents and copies (whether written, printed, electronic, recorded or otherwise and wherever located) made, compiled or acquired by him during his employment with the Employer or relating to the business or affairs of the Employer, Hologic, Inc. or any other Group Company or the business contacts of any of them,

in the Employee's possession or under his control.
		
	9.2
	The Employee shall, before the Termination Date, erase irretrievably any information relating to the business or affairs of the Employer, Hologic, Inc. or any other Group Company or the business contacts of any of them from computer and communications systems and devices owned or used by him outside the premises of the Employer or any other Group Company, including such systems and data storage services provided by third parties (to the extent technically practicable).

		
	9.3
	The Employee shall, if requested to do so by the Employer, provide a signed statement that he has complied fully with his obligations under clause 9.1 and clause 9.2 and shall provide it with such reasonable evidence of compliance as may be requested.

		
	10.
	EMPLOYEE WARRANTIES AND ACKNOWLEDGMENTS

		
	10.1
	As at the date of this agreement, the Employee warrants and represents to the Employer that there are no circumstances of which the Employee is aware or of which the Employee ought reasonably to be aware that would amount to a repudiatory breach by the Employee of any express or implied term of the Employee's contract of employment that would entitle (or would have entitled) the Employer to terminate the Employee's employment without notice or payment in lieu of notice and any payment to the Employee pursuant to clause 3 and any benefit provided pursuant to clause 4 is conditional on this being so. 

		
	10.2
	The Employee agrees to make himself available to, and to cooperate with, the Employer, Hologic, Inc. or any other Group Company or the advisers of any of them in any internal investigation or administrative, regulatory, judicial or quasi-judicial proceedings. The Employee acknowledges that this could involve, but is not limited to, responding to or defending any regulatory or legal process, providing information in relation to any such process, preparing witness statements and giving evidence in person on behalf of the Employer, Hologic, Inc. or any other Group Company. The Employer shall reimburse or procure the reimbursement of any reasonable expenses incurred by the Employee as a consequence of complying with his obligations under this clause, provided that such expenses are approved in advance by the Employer.

7

		
	11.
	EMPLOYER WARRANTY AND ACKNOWLEDGMENT 

		
	11.1
	The Employer warrants and represents that at this time it is not aware of any claims or liabilities against the Employee, either in his individual capacity as an employee, or in his capacity as a director of  Hologic IP Ltd, Hologic Ltd, Hologic GGO 4 Ltd, Hologic Hub Ltd, Hologic IP Ltd and Hologic (UK) Limited.

		
	11.2
	The Employer acknowledges that it has D&O cover and will maintain this in respect of the period of the directorships.    

		
	12.
	RESIGNATION FROM OFFICES

		
	12.1
	The Employee will resign with effect from the Termination Date as a director of the Employer, and of each subsidiary of Hologic, Inc. on whose board he serves, including, but not limited to, Hologic Ltd., Hologic GGO 4 Ltd, Hologic Hub Ltd, Hologic IP Ltd and Hologic (UK) Limited and from all other offices that he holds in or on behalf of the Employer or any Group Company.  

		
	12.2
	The Employee will, at the same time as signing and returning a copy of this Agreement, sign and return to the Employer the letter of resignation attached as Schedule 3.

		
	12.3
	The Employee appoints the Company to be his attorney in his name and on his behalf solely to sign, execute or do any such instrument or thing and generally to use his name in order to give the Employer (or its nominee) the full benefit of the provisions of this clause.

		
	13.
	CONFIDENTIALITY AND OTHER POST TERMINATION OBLIGATIONS

The Employee acknowledges that, without prejudice to any other obligations that he may have to the Employer or Hologic, Inc. that continue after the Termination Date, he will remain bound by the following obligations in his Service Agreement: clause 10 (Confidential Information), Clause 13 (Copyright, Inventions and Patents) and 17 (Restrictions on Termination of Employment) and, by executing this Settlement Agreement, he affirms and repeats all such obligations and undertakes to abide by them.
		
	14.
	CONFIDENTIALITY OF AGREEMENT AND NO DEROGATORY STATEMENTS

		
	14.1
	The Employee and the Employer confirm that they have kept and agree to keep the existence and terms of this agreement and the circumstances concerning the termination of the Employee's employment confidential, except where such disclosure is to HM Revenue & Customs, required by law (such as the United States Securities and Exchange Commission) or (where necessary or appropriate) to:

8

		
	14.1.1
	the Employee's spouse, civil partner or partner, immediate family or legal or professional advisers, provided that they agree to keep the information confidential; or

		
	14.1.2
	the Employee's insurer for the purposes of processing a claim for loss of employment; or

		
	14.1.3
	the Employee's recruitment consultant or prospective employer to the extent necessary to discuss his employment history.

		
	14.1
	The Employer may also disclose the existence and terms of this agreement to the Employer's officers, employees or legal or professional advisers.

		
	14.2
	The Employee shall not make any adverse or derogatory comment about the Employer, its directors or employees and the Employer shall use reasonable endeavours to ensure that its directors and members of senior management shall not make any adverse or derogatory comment about the Employee. The Employee shall not do anything which shall, or may, bring the Employer, its directors or employees into disrepute and the Employer shall use reasonable endeavours to ensure that its directors and members of senior management shall not do anything that shall, or may, bring the Employee into disrepute.

		
	14.3
	Nothing in this clause 14 shall prevent the Employee from making a protected disclosure under section 43A of the Employment Rights Act 1996 and nothing in this clause 14 shall prevent the Employer from making such disclosure as it is required by law to make.

		
	15.
	ENTIRE AGREEMENT

		
	15.1
	Each party on behalf of itself acknowledges and agrees with the other parties that (save as expressly referred to herein):

		
	15.1.1
	this agreement an constitutes the entire agreement between the parties and supersedes and extinguishes all agreements, promises, assurances, warranties, representations and understandings between them whether written or oral, relating to its subject matter;

		
	15.1.2
	in entering into this agreement it does not rely on and shall have no remedies in respect of,  any statement, representation, assurance or warranty (whether made innocently or negligently) that is not set out in this agreement; and

		
	15.1.3
	it shall have no claim for innocent or negligent misrepresentation or negligent misstatement based on any statement in this agreement.

9

		
	15.2
	Nothing in this agreement shall, however, operate to limit or exclude any liability for fraud.

		
	16.
	VARIATION

No variation of this agreement shall be effective unless it is in writing and signed by the parties (or their authorised representatives).
		
	17.
	THIRD PARTY RIGHTS

Any Group Company and any officer or employee of the Employer, Hologic, Inc. and of any other Group Company (each a Third Party) may enforce the terms of this Agreement, subject to and in accordance with the provisions of the Contracts (Rights of Third Parties) Act 1999 (the 1999 Act), but the Parties hereto may rescind, vary, waive, assign or release any or all of their respective rights and obligations under this Agreement without the consent of any Third Party.  Other than as provided in this paragraph, the Parties do not intend that any term of this Agreement shall be enforceable solely by virtue of the 1999 Act by any person who is not a party to this Agreement.
		
	18.
	SUCCESSORS 

		
	18.1
	This Agreement shall be binding upon and shall inure to the benefit of the Employer, and its successors and assigns, and the Employer shall require any successors and assigns to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Employer would be required to perform it if no such succession or assignment had taken place. 

		
	18.2 
	Neither this Agreement nor any right or interest hereunder shall be assignable or transferable by the Executive, his beneficiaries or legal representatives, except by will or by the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Executive’s personal representative.

		
	1.
	GOVERNING LAW 

This agreement and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with the law of England and Wales.
		
	2.
	JURISDICTION

Each party irrevocably agrees that the courts of England and Wales shall have exclusive jurisdiction to settle any dispute, claim arising out of or in connection with this agreement or its subject matter or formation (including non-contractual disputes or claims).

10

		
	3.
	SUBJECT TO CONTRACT AND WITHOUT PREJUDICE

This agreement shall be deemed to be without prejudice and subject to contract until such time as it is signed by both parties and dated, when it shall be treated as an open document evidencing a binding agreement.
		
	4.
	COUNTERPARTS

This agreement may be executed and delivered in any number of counterparts, each of which, when executed, shall constitute a duplicate original, but all the counterparts shall together constitute the one agreement.
		
	5.
	SEVERABILITY 

The provisions of this Agreement are severable, and the invalidity of any provision shall not affect the validity of any other provision. In the event that any court of competent jurisdiction shall determine that any provision of this Agreement or the application thereof is unenforceable because of the duration or scope thereof, the parties hereto agree that said court in making such determination shall have the power to reduce the duration and scope of such provision to the extent necessary to make it enforceable, and that the Agreement in its reduced form shall be valid and enforceable to the full extent permitted by law.

11

Schedule 1:  Claims
		
	(a)
	for breach of contract or wrongful dismissal;

		
	(b)
	for unfair dismissal and related claims, under sections 93 and 111 of the Employment Rights Act 1996;

		
	(c)
	for a statutory redundancy payment, under section 163 of the Employment Rights Act 1996;

		
	(d)
	in relation to an unauthorised deduction from wages or unauthorised payment, under section 23 of the Employment Rights Act 1996;

		
	(e)
	for unlawful detriment under section 48 of the Employment Rights Act 1996;

		
	(f)
	for unfair dismissal or unlawful detriment for having made a protected disclosure under the Employment Rights Act 1996;

		
	(g)
	in relation to employment particulars and itemised pay statements, under section 11 of the Employment Rights Act 1996;

		
	(h)
	in relation to guarantee payments, under section 34 of the Employment Rights Act 1996;

		
	(i)
	in relation to suspension from work, under section 70 of the Employment Rights Act 1996;

		
	(j)
	in relation to parental rights and flexible working, under sections 80 and 80H of the Employment Rights Act 1996;

		
	(k)
	in relation to time off work, under sections 51, 54, 57, 57B, 60, 63 and 63C of the Employment Rights Act 1996;

		
	(l)
	in relation to working time or holiday pay, under regulation 30 of the Working Time Regulations 1998;

		
	(m)
	in relation to the national minimum wage, under sections 11, 18, 19D and 24 of the National Minimum Wage Act 1998;

		
	(n)
	for equality of terms, under sections 120 and 127 of the Equality Act 2010 ;

		
	(o)
	for pregnancy or maternity discrimination, direct or indirect discrimination, harassment or victimisation related to sex, marital or civil partnership status, pregnancy or maternity or gender reassignment under the Equality Act 2010

		
	(p)
	for direct or indirect discrimination, harassment or victimisation related to race under the Equality Act 2010 

12

		
	(q)
	for direct or indirect discrimination, harassment or victimisation related to disability, discrimination arising from disability, or failure to make adjustments under section 120 of the Equality Act 2010 

		
	(r)
	for breach of the provisions of  the Protection of Harassment Act 1997;

		
	(s)
	for less favourable treatment on the grounds of part-time status, under regulation 8 of the Part-Time Workers (Prevention of Less Favourable Treatment) Regulations 2000;

		
	(t)
	for less favourable treatment on the grounds of fixed-term status, under regulation 7 of the Fixed-Term Employees (Prevention of Less Favourable Treatment) Regulations 2002;

		
	(u)
	for direct or indirect discrimination, harassment or victimisation related to religion or belief, under the Equality Act 2010 an

		
	(v)
	for direct or indirect discrimination, harassment or victimisation related to sexual orientation, under the Equality Act 2010 

		
	(w)
	for direct or indirect discrimination, harassment or victimisation related to age, under the Equality Act 2010 

		
	(x)
	under regulations 27 and 32 of the Transnational Information and Consultation etc. Regulations 1999;

		
	(y)
	under regulations 29 and 33 of the Information and Consultation of Employees Regulations 2004;

		
	(z)
	under regulations 45 and 51 of the Companies (Cross-Border Mergers) Regulations 2007;

		
	(aa)
	under paragraphs 4 and 8 of the Schedule to the Occupational and Personal Pension Schemes (Consultation by Employers and Miscellaneous Amendment) Regulations 2006;

		
	(bb)
	under sections 68A, 87, 137, 145A, 145B, 146, 168, 168A, 169, 170, 174 and 192 of the Trade Union and Labour Relations (Consolidation) Act 1992;

		
	(cc)
	in relation to the obligations to elect appropriate representatives or any entitlement to a protective award or compensation under the Transfer of Undertakings (Protection of Employment) Regulations 2006;

		
	(dd)
	for failure to comply with obligations under the Human Rights Act 1998;

		
	(ee)
	for failure to comply with obligations under the Data Protection Act 1998;

		
	(ff)
	in relation to the right to be accompanied under section 11 of the Employment Relations Act 1999;

13

		
	(gg)
	in relation to refusal of employment, refusal of employment agency services and detriment under regulations 5, 6 and 9 of the Employment Relations Act 1999 (Blacklists) Regulations 2010;

		
	(hh)
	in relation to the right to request time off for study or training under section 63I of the Employment Rights Act 1996; and

		
	(ii)
	in relation to the right to equal treatment, access to collective facilities and amenities, access to employment vacancies and the right not to be subjected to a detriment under regulations 5, 12, 13 and 17(2) of the Agency Workers Regulations 2010.

		
	(jj)
	arising as a consequence of the United Kingdom's membership of the European Union. 

		
	(kk)
	for personal injury claims, save as expressly excepted elsewhere in this Agreement.

14

Schedule 2: Adviser’s Certificate

[ON HEADED NOTEPAPER OF ADVISER]

To Hologic IP Ltd and
Hologic, Inc.
For the attention of Mr. John Griffin

11/1/16

Dear Sirs,

I am writing in connection with the agreement between my client, Claus Egstrand, Hologic IP  Ltd and Hologic, Inc. dated 8th January 2016 (Agreement) to confirm that:

1. I, Kathryn Coyle of Kidd Rapinet, whose address is 33 Queen Street, Maidenhead, Berkshire SL6 1ND, am a Solicitor of the Senior Courts of England and Wales who holds a current practising certificate.

2. I have given Claus Egstrand legal advice on the terms and effect of the Agreement.

3. I gave the advice to Claus Egstrand as a relevant independent adviser within the meaning of the Relevant Legislation, as defined in clause 1.1 of the Agreement.

4. There is now in force (and was in force at the time I gave the advice referred to above) a policy of insurance or an indemnity provided for members of a profession or professional body covering the risk of claim by Claus Egstrand in respect of loss arising in consequence of the advice I have given him.

Yours faithfully,

/s/ Kathryn Coyle

Kathryn Coyle
11.1.16

15

Schedule 3:  Resignation
To the Boards of Directors of

Hologic IP Ltd
Hologic Ltd
Hologic GGO 4 Ltd
Hologic Hub Ltd
Hologic IP Ltd
Hologic (UK) Limited

8th January 2016

Dear Sirs

Please take this letter as my resignation as a director of all subsidiaries of Hologic, Inc. on whose board I serve, including, but not limited to, the above companies with effect from 8 January 2016.

I hereby acknowledge and confirm that I have no claim or right of action of any kind for compensation or otherwise against any of the above companies or any of their employees in respect of the termination of my office.  To the extent that any such claim or right of action exists or may exist, I irrevocably waive such claim or right of action and release and forever discharge the above companies and its or their officers and employees from all and any liability in respect thereof.

This document has been executed as a deed.

Yours faithfully

Signed as a deed by Claus Egstrand
/s/ Claus Egstrand

in the presence of:
/s/ Stefanie Gooding

Name:    Stefanie Gooding
Address: Otto von Guericke Ring, 15, Wiesbaden
Occupation:  Executive Assistant

16

	
		
	Signed on behalf of Hologic IP Ltd
	/s/ Robert W. McMahon

	 
	 

	Signed on behalf of Hologic Inc
	/s/ Robert W. McMahon

	 
	 

	Signed as a deed by
Claus Egstrand
	/s/ Claus Egstrand

	 
	 

	In the presence of
	 

	/s/ Stefanie Gooding
	 

	Signed
	 

	 
	 

	Stefanie Gooding
	 

	Name
	 

	 
	 

	Executive Assistant
	 

	Occupation
	 

	 
	 

	Hologic
	 

	 
	 

	Otto von Guericke Ring 15
	 

	 
	 

	Wiesbaden
	 

	 
	 

	Address
	 

17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}]]